Updated:
PureTech Ventures
PureTech Ventures is an early-stage VC firm operating from Mumbai and Boston, creating digital-health and AI companies from academic research.
PureTech Ventures
PureTech Ventures operates from dual hubs in Boston and Mumbai, bridging the US life-sciences ecosystem with India's software and AI talent base. The firm was established to convert academic and research breakthroughs into venture-backed startups, specializing in early-stage company creation within digital health and deep technology. Its model draws on principal-level operating support, not just capital allocation, to catalyze founding teams building at the intersection of biology and computation. The partnership targets pre-seed and seed-stage opportunities across digital health, enterprise AI/ML, and enterprise software sectors. Deployment focuses on company formation—PureTech often works alongside academic founders and research institutions to build intellectual-property-based businesses from the ground up. Confirmed active interests span computational biology, clinical workflow automation, and machine-learning applications in diagnostics and drug discovery. No publicly disclosed fund commitments or SPV structures are available; the firm has historically operated on a deal-by-deal formation basis rather than drawing from a committed blind pool. PureTech maintains a lean, cross-border team with professionals in Boston and Mumbai. No specific professional headcount is disclosed. The Mumbai office concentrates on engineering and product-building capacity, while Boston anchors scientific and clinical networks. No associated philanthropic foundations, real-asset arms, or club memberships are on the public record. No verifiable operational event from the last 24 months can be confirmed. The firm differentiates from standard venture funds by operating as a hybrid across US and Indian ecosystems, emphasizing company creation rather than passive investment in existing startups. PureTech Ventures' structural distinctiveness rests on combining deep-tech US academic deal flow with India-based software development execution—a model that allows capital-efficient scaling for early-stage health and enterprise AI ventures.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Mumbai
Corporate office
Mumbai, India
Additional offices
Boston, MA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at PureTech Ventures?
Specific named investment principals are not disclosed in the public record. PureTech Ventures operates as a general partnership, and investment decisions are made collectively by its transcontinental team based in Boston and Mumbai. The firm does not publicly identify a managing partner or CIO for the entity.
Does PureTech Ventures operate as a single fund or a company-creation studio?
PureTech Ventures acts primarily as a company builder rather than a traditional fund, co-founding startups alongside academic scientists and domain experts. It has not publicly announced a classic blind-pool venture fund structure. The firm provides early-stage capital and operational scaffolding to form new entities rooted in university research.
How does PureTech Ventures source its deal flow?
Deal flow originates through deep relationships with academic institutions and research networks in Boston, combined with the firm's access to India's technical talent pool. PureTech identifies scientific breakthroughs amenable to commercialization and then assembles founding teams to build software-driven companies around that IP. No proprietary quantitative sourcing platform is disclosed.
Which sectors does PureTech Ventures explicitly avoid?
No explicit sector exclusions are publicly stated. Based on the firm's formation focus and past activity, PureTech concentrates on digital health and enterprise AI/ML; adjacent sectors like consumer internet, direct-to-consumer products, and traditional manufacturing are outside its observable scope but not ruled out by any formal policy.
What is PureTech Ventures' relationship with the pharmaceutical industry?
PureTech Ventures bridges academic life sciences with scalable software and AI applications; it is not a pharmaceutical company itself. While its digital-health portfolio may intersect with pharma workflows—such as clinical trial automation or diagnostics—there is no evidence of a structured partnership or corporate venture relationship with any major pharmaceutical firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: